Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in ChildrenJoanne Kurtzberg, Elizabeth Burke, Eneida R. Nemecek et al.|Transplantation and Cellular Therapy|2020Cited by 65
Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host DiseaseJoanne Kurtzberg, Donna Skerrett, Susan E. Prockop et al.|Transplantation and Cellular Therapy|2015Cited by 1